{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T11:20:26Z","timestamp":1769599226057,"version":"3.49.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,26]]},"DOI":"10.7759\/cureus.25372","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:43:05Z","timestamp":1653612185000},"source":"Crossref","is-referenced-by-count":3,"title":["A Systematic Review of the Role of Runt-Related Transcription Factor 1 (RUNX1) in the Pathogenesis of Hematological Malignancies in Patients With Inherited Bone Marrow Failure Syndromes"],"prefix":"10.7759","author":[{"given":"Janan","family":"Illango","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archana","family":"Sreekantan Nair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajvi","family":"Gor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ransirini","family":"Wijeratne Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mushrin","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nabeel A","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pousette","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.236","article-title":"Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia","volume":"30","author":"Antony-Debr\u00e9 I","year":"2016","unstructured":"Antony-Debr\u00e9 I, Duployez N, Bucci M, et al.. Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia. Leukemia. 2016, 30:999-1002. 10.1038\/leu.2015.236","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2014.08.001","article-title":"Inherited predisposition to acute myeloid leukemia","volume":"51","author":"Godley LA","year":"2014","unstructured":"Godley LA. Inherited predisposition to acute myeloid leukemia. Semin Hematol. 2014, 51:306-21. 10.1053\/j.seminhematol.2014.08.001","journal-title":"Semin Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22974","article-title":"Molecular mechanisms that produce secondary MDS\/AML by RUNX1\/AML1 point mutations","volume":"112","author":"Harada Y","year":"2011","unstructured":"Harada Y, Harada H. Molecular mechanisms that produce secondary MDS\/AML by RUNX1\/AML1 point mutations. J Cell Biochem. 2011, 112:425-32. 10.1002\/jcb.22974","journal-title":"J Cell Biochem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-007-0337-z","article-title":"Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?","volume":"86","author":"G\u00f6hring G","year":"2007","unstructured":"G\u00f6hring G, Karow A, Steinemann D, et al.. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?. Ann Hematol. 2007, 86:733-9. 10.1007\/s00277-007-0337-z","journal-title":"Ann Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood R","year":"2017","unstructured":"Sood R, Kamikubo Y, Liu P. Role of RUNX1 in hematological malignancies. Blood. 2017, 129:2070-82. 10.1182\/blood-2016-10-687830","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2019.0304","article-title":"Role of RUNX family transcription factors in DNA damage response","volume":"43","author":"Samarakkody AS","year":"2020","unstructured":"Samarakkody AS, Shin NY, Cantor AB. Role of RUNX family transcription factors in DNA damage response. Mol Cells. 2020, 43:99-106. 10.14348\/molcells.2019.0304","journal-title":"Mol Cells"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2019.0252","article-title":"The clinical, molecular, and mechanistic basis of RUNX1 mutations identified in hematological malignancies","volume":"43","author":"Yokota A","year":"2020","unstructured":"Yokota A, Huo L, Lan F, Wu J, Huang G. The clinical, molecular, and mechanistic basis of RUNX1 mutations identified in hematological malignancies. Mol Cells. 2020, 43:145-52. 10.14348\/molcells.2019.0252","journal-title":"Mol Cells"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14348\/molcells.2020.0010","article-title":"RUNX1 mutations in the leukemic progression of severe congenital neutropenia","volume":"43","author":"Olofsen PA","year":"2020","unstructured":"Olofsen PA, Touw IP. RUNX1 mutations in the leukemic progression of severe congenital neutropenia. Mol Cells. 2020, 43:139-44. 10.14348\/molcells.2020.0010","journal-title":"Mol Cells"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100074","article-title":"Malignant transformation involving CXXC4 mutations identified in a leukemic progression model of severe congenital neutropenia","volume":"1","author":"Olofsen PA","year":"2020","unstructured":"Olofsen PA, Fatrai S, van Strien PM, et al.. Malignant transformation involving CXXC4 mutations identified in a leukemic progression model of severe congenital neutropenia. Cell Rep Med. 2020, 1:100074. 10.1016\/j.xcrm.2020.100074","journal-title":"Cell Rep Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/nature12052","article-title":"Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX","volume":"497","author":"Ko M","year":"2013","unstructured":"Ko M, An J, Bandukwala HS, et al.. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature. 2013, 497:122-6. 10.1038\/nature12052","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.402594","article-title":"Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation","volume":"288","author":"Wu D","year":"2013","unstructured":"Wu D, Ozaki T, Yoshihara Y, Kubo N, Nakagawara A. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation. J Biol Chem. 2013, 288:1353-64. 10.1074\/jbc.M112.402594","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.471","article-title":"Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia","volume":"105","author":"Hou HA","year":"2011","unstructured":"Hou HA, Kuo YY, Liu CY, et al.. Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia. Br J Cancer. 2011, 105:1927-33. 10.1038\/bjc.2011.471","journal-title":"Br J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021, 18:e1003583. 10.1371\/journal.pmed.1003583","journal-title":"PLoS Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0432-0","article-title":"Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders","volume":"11","author":"Latger-Cannard V","year":"2016","unstructured":"Latger-Cannard V, Philippe C, Bouquet A, et al.. Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders. Orphanet J Rare Dis. 2016, 11:49. 10.1186\/s13023-016-0432-0","journal-title":"Orphanet J Rare Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000494645","article-title":"Thrombocytopenia and predisposition to acute myeloid leukemia due to mosaic ring 21 with loss of RUNX1: cytogenetic and molecular characterization","volume":"9","author":"Vormittag-Nocito E","year":"2019","unstructured":"Vormittag-Nocito E, Ni H, Schmidt ML, Lindgren V. Thrombocytopenia and predisposition to acute myeloid leukemia due to mosaic ring 21 with loss of RUNX1: cytogenetic and molecular characterization. Mol Syndromol. 2019, 9:306-11. 10.1159\/000494645","journal-title":"Mol Syndromol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2016.207","article-title":"RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features","volume":"30","author":"Gaidzik VI","year":"2016","unstructured":"Gaidzik VI, Teleanu V, Papaemmanuil E, et al.. RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features. Leukemia. 2016, 30:2282. 10.1038\/leu.2016.207","journal-title":"Leukemia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-09-381665","article-title":"The genetic basis of myelodysplasia and its clinical relevance","volume":"122","author":"Cazzola M","year":"2013","unstructured":"Cazzola M, Della Porta MG, Malcovati L. The genetic basis of myelodysplasia and its clinical relevance. Blood. 2013, 122:4021-34. 10.1182\/blood-2013-09-381665","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.336","article-title":"Landscape of genetic lesions in 944 patients with myelodysplastic syndromes","volume":"28","author":"Haferlach T","year":"2014","unstructured":"Haferlach T, Nagata Y, Grossmann V, et al.. Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia. 2014, 28:241-7. 10.1038\/leu.2013.336","journal-title":"Leukemia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4065\/80.5.681","article-title":"Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity","volume":"80","author":"Steensma DP","year":"2005","unstructured":"Steensma DP, List AF. Genetic testing in the myelodysplastic syndromes: molecular insights into hematologic diversity. Mayo Clin Proc. 2005, 80:681-98. 10.4065\/80.5.681","journal-title":"Mayo Clin Proc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.48","article-title":"RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation","volume":"23","author":"Kuo MC","year":"2009","unstructured":"Kuo MC, Liang DC, Huang CF, Shih YS, Wu JH, Lin TL, Shih LY. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation. Leukemia. 2009, 23:1426-31. 10.1038\/leu.2009.48","journal-title":"Leukemia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-2203","article-title":"Biological activities of RUNX1 mutants predict secondary acute leukemia transformation from chronic myelomonocytic leukemia and myelodysplastic syndromes","volume":"21","author":"Tsai SC","year":"2015","unstructured":"Tsai SC, Shih LY, Liang ST, et al.. Biological activities of RUNX1 mutants predict secondary acute leukemia transformation from chronic myelomonocytic leukemia and myelodysplastic syndromes. Clin Cancer Res. 2015, 21:3541-51. 10.1158\/1078-0432.CCR-14-2203","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.043919","article-title":"Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia","volume":"96","author":"Grossmann V","year":"2011","unstructured":"Grossmann V, Kern W, Harbich S, et al.. Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia. Haematologica. 2011, 96:1874-7. 10.3324\/haematol.2011.043919","journal-title":"Haematologica"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-11-817510","article-title":"PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia","volume":"131","author":"Zhang Y","year":"2018","unstructured":"Zhang Y, Gao Y, Zhang H, et al.. PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia. Blood. 2018, 131:2256-61. 10.1182\/blood-2017-11-817510","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0479-8","article-title":"The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution","volume":"33","author":"Singhal D","year":"2019","unstructured":"Singhal D, Wee LY, Kutyna MM, et al.. The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distribution. Leukemia. 2019, 33:2842-53. 10.1038\/s41375-019-0479-8","journal-title":"Leukemia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2015.95","article-title":"Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors","volume":"5","author":"Cerquozzi S","year":"2015","unstructured":"Cerquozzi S, Tefferi A. Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors. Blood Cancer J. 2015, 5:e366. 10.1038\/bcj.2015.95","journal-title":"Blood Cancer J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-02-832253","article-title":"Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease","volume":"132","author":"Branford S","year":"2018","unstructured":"Branford S, Wang P, Yeung DT, et al.. Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease. Blood. 2018, 132:948-61. 10.1182\/blood-2018-02-832253","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0119-8","article-title":"Molecular patterns in cytopenia patients with or without evidence of myeloid neoplasm-a comparison of 756 cases","volume":"32","author":"Baer C","year":"2018","unstructured":"Baer C, Pohlkamp C, Haferlach C, Kern W, Haferlach T. Molecular patterns in cytopenia patients with or without evidence of myeloid neoplasm-a comparison of 756 cases. Leukemia. 2018, 32:2295-8. 10.1038\/s41375-018-0119-8","journal-title":"Leukemia"},{"key":"ref28","article-title":"Myeloid\/lymphoid neoplasms with FGFR1 rearrangement","volume":"59","author":"Strati P","year":"2018","unstructured":"Strati P, Tang G, Duose DY, et al.. Myeloid\/lymphoid neoplasms with FGFR1 rearrangement. Leuk Lymphoma. 2018, 59:1672-6. 1080\/10428194.2017.1397663","journal-title":"Leuk Lymphoma"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-117046","article-title":"Mutational spectrum of Fanconi anemia associated myeloid neoplasms","volume":"229","author":"Chao MM","year":"2017","unstructured":"Chao MM, Thomay K, Goehring G, et al.. Mutational spectrum of Fanconi anemia associated myeloid neoplasms. Klin Padiatr. 2017, 229:329-34. 10.1055\/s-0043-117046","journal-title":"Klin Padiatr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-308726","article-title":"Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions","volume":"117","author":"Quentin S","year":"2011","unstructured":"Quentin S, Cuccuini W, Ceccaldi R, et al.. Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1\/AML1 lesions. Blood. 2011, 117:e161-70. 10.1182\/blood-2010-09-308726","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-538025","article-title":"Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis","volume":"123","author":"Skokowa J","year":"2014","unstructured":"Skokowa J, Steinemann D, Katsman-Kuipers JE, et al.. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. 2014, 123:2229-37. 10.1182\/blood-2013-11-538025","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2014.305","article-title":"Posttranslational modifications of RUNX1 as potential anticancer targets","volume":"34","author":"Goyama S","year":"2015","unstructured":"Goyama S, Huang G, Kurokawa M, Mulloy JC. Posttranslational modifications of RUNX1 as potential anticancer targets. Oncogene. 2015, 34:3483-92. 10.1038\/onc.2014.305","journal-title":"Oncogene"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-526301","article-title":"Marrow failure: a window into ribosome biology","volume":"124","author":"Ruggero D","year":"2014","unstructured":"Ruggero D, Shimamura A. Marrow failure: a window into ribosome biology. Blood. 2014, 124:2784-92. 10.1182\/blood-2014-04-526301","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1615\/critrevoncog.v16.i1-2.80","article-title":"RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making","volume":"16","author":"Mangan JK","year":"2011","unstructured":"Mangan JK, Speck NA. RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making. Crit Rev Oncog. 2011, 16:77-91. 10.1615\/critrevoncog.v16.i1-2.80","journal-title":"Crit Rev Oncog"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22980","article-title":"AML1\/RUNX1 gene point mutations in childhood myeloid malignancies","volume":"57","author":"Migas A","year":"2011","unstructured":"Migas A, Savva N, Mishkova O, Aleinikova OV. AML1\/RUNX1 gene point mutations in childhood myeloid malignancies. Pediatr Blood Cancer. 2011, 57:583-7. 10.1002\/pbc.22980","journal-title":"Pediatr Blood Cancer"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20160632","article-title":"RUNX transcription factors at the interface of stem cells and cancer","volume":"474","author":"Deltcheva E","year":"2017","unstructured":"Deltcheva E, Nimmo R. RUNX transcription factors at the interface of stem cells and cancer. Biochem J. 2017, 474:1755-68. 10.1042\/BCJ20160632","journal-title":"Biochem J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.6652","article-title":"RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures","volume":"30","author":"Mendler JH","year":"2012","unstructured":"Mendler JH, Maharry K, Radmacher MD, et al.. RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures. J Clin Oncol. 2012, 30:3109-18. 10.1200\/JCO.2011.40.6652","journal-title":"J Clin Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.7379","article-title":"Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes","volume":"30","author":"Bejar R","year":"2012","unstructured":"Bejar R, Stevenson KE, Caughey BA, et al.. Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol. 2012, 30:3376-82. 10.1200\/JCO.2011.40.7379","journal-title":"J Clin Oncol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12614","article-title":"Recent advances in myelodysplastic syndromes: molecular pathogenesis and its implications for targeted therapies","volume":"106","author":"Harada H","year":"2015","unstructured":"Harada H, Harada Y. Recent advances in myelodysplastic syndromes: molecular pathogenesis and its implications for targeted therapies. Cancer Sci. 2015, 106:329-36. 10.1111\/cas.12614","journal-title":"Cancer Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa J","year":"2017","unstructured":"Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017, 3:17032. 10.1038\/nrdp.2017.32","journal-title":"Nat Rev Dis Primers"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08216.x","article-title":"Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy","volume":"150","author":"Rosenberg PS","year":"2010","unstructured":"Rosenberg PS, Zeidler C, Bolyard AA, et al.. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol. 2010, 150:196-9. 10.1111\/j.1365-2141.2010.08216.x","journal-title":"Br J Haematol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.1","article-title":"Game of clones: the genomic evolution of severe congenital neutropenia","volume":"2015","author":"Touw IP","year":"2015","unstructured":"Touw IP. Game of clones: the genomic evolution of severe congenital neutropenia. Hematology Am Soc Hematol Educ Program. 2015, 2015:1-7. 10.1182\/asheducation-2015.1.1","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.4.683","article-title":"Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia\/acute myeloid leukemia-derived mutation in the G-CSF receptor gene","volume":"189","author":"Hermans MH","year":"1999","unstructured":"Hermans MH, Antonissen C, Ward AC, Mayen AE, Ploemacher RE, Touw IP. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia\/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med. 1999, 189:683-92. 10.1084\/jem.189.4.683","journal-title":"J Exp Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/57412-a-systematic-review-of-the-role-of-runt-related-transcription-factor-1-runx1-in-the-pathogenesis-of-hematological-malignancies-in-patients-with-inherited-bone-marrow-failure-syndromes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:45Z","timestamp":1707507345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/57412-a-systematic-review-of-the-role-of-runt-related-transcription-factor-1-runx1-in-the-pathogenesis-of-hematological-malignancies-in-patients-with-inherited-bone-marrow-failure-syndromes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,26]]},"references-count":43,"URL":"https:\/\/doi.org\/10.7759\/cureus.25372","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,26]]}}}